Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

 v2.3.0.11
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
6 Months Ended
Jul. 02, 2011
Jul. 03, 2010
Operating activities    
Net income $ 4,209,362 $ 1,160,368
Adjustments to reconcile net income to net cash (used in) provided by continuing operating activities:    
Depreciation expense 1,536,482 1,316,675
Amortization of deferred charges 14,412 0
Deferred income taxes 62,072 (130,545)
Provision for losses on accounts receivable 75,300 149,519
Provision for losses on inventory (127,000) 7,375
Gain on sale of property, plant and equipment (33,835) (19,991)
Cash value of life insurance (36,000) (52,163)
Environmental reserves 14,534 (137,815)
Issuance of treasury stock for director fees 74,950 74,981
Employee stock option and stock grant compensation 123,180 89,341
Changes in operating assets and liabilities:    
Accounts receivable (4,507,128) (6,000,068)
Inventories (12,091,330) (10,193,025)
Other assets and liabilities 80,113 295,671
Accounts payable 5,142,824 296,615
Accrued expenses 2,321,420 3,936,037
Income taxes payable 398,113 (1,696,841)
Net cash used in operating activities (2,742,531) (10,903,866)
Investing activities    
Purchases of property, plant and equipment (1,330,469) (3,872,808)
Proceeds from sale of property, plant and equipment 45,450 30,600
Net cash used in investing activities (1,285,019) (3,842,208)
Financing activities    
Net borrowings from long-term debt 3,872,164 2,312,810.00
Dividends paid 0 (1,581,084)
Proceeds from exercised stock options 161,902 16,746
Net cash provided by (used in) financing activities 4,034,066 748,472
Increase (decrease) in cash and cash equivalents 6,516 (13,997,602)
Cash and cash equivalents at beginning of period 108,902 14,096,557
Cash and cash equivalents at end of period $ 115,418 $ 98,955